Best Myeloproliferative Neoplasms Podcasts (2025)

1
Hema Now: Episode 24: Understanding Myeloproliferative Neoplasms 32:58

Play Pause

2d ago32:58

32:58

In this episode, host Jonathan Sackier is joined by Andrew Dunbar, Assistant Professor in the Department of Hematopoietic Biology and Malignancy at the University of Texas MD Anderson Cancer Center, Houston, USA. Dunbar discusses his research into myeloproliferative neoplasms, what drives disease progression and resistance, and promising targets fo…

1
Onc Now: Episode 25: The Changing Landscape of Breast Cancer Care 27:06

6h ago27:06

27:06

Tolaney focuses on advancing breast cancer treatment through innovative clinical research. She has been instrumental in developing novel therapies and leading key clinical trials, particularly for early-stage HER2-positive breast cancer.   Timestamps  00:09 – Introduction 01:12 – What is HER2-positive breast cancer? 03:00 – Key trials Tolaney has l…

1
Alcohol in Hepatology: Mental Health Challenges in Alcohol Use Disorder 10:34

4h ago10:34

10:34

Stephanie Rutledge joins host Saranya Ravindran to unpack the mental health dimensions of alcohol use disorder. From co-occurring conditions and behavioural strategies like motivational interviewing to the role of family and community support, this episode explores how integrated care can strengthen recovery. Timestamps: 1:44 – Why hepatology 3:25 …

1
Quickfire: Alcohol in Hepatology 5:27

3h ago5:27

5:27

In this rapid-fire episode, Stephanie Rutledge answers key questions on alcohol in hepatology, from mental health challenges in alcohol use disorder to transplant misconceptions, emerging therapies, and the impact of lifestyle changes like Dry January. It provides a concise, insightful overview in just minutes. Timestamps: 1:08 – Treating alcohol u…

1
Pancreatic Cancer Progress: Expert Insights on Treatment Choices and Collaborating with Patients 13:57

4d ago13:57

13:57

Listen in as Zev A. Wainberg, MD; Paul E. Oberstein, MD; and Mark O’Hara, MD, discuss the evolving treatment landscape for metastatic pancreatic cancer, including: How patients often present with disease-related symptoms Treatment selection considerations for the first-line and second-line setting How to approach palliative care discussions with pa…

1
“Ironing out” Tet2-mutant HSPCs; A CAR-T “license to kill” in T cell leukemia/lymphoma; insights on cHL genetics, through the lens of ctDNA 20:43

4d ago20:43

20:43

In this week's episode, we'll learn about how TET2 is often mutated in myeloid malignancies and clonal hematopoiesis. In new work, expansion of Tet2-mutant HSPCs was dependent on Ncoa4, the cargo receptor mediating ferritinophagy. We’ll iron out the implications. After that: a double-oh-seven license to kill in T-cell leukemia/lymphoma. WU-CART-007…

1
Bonus Episodes: The Diagnostic Odyssey of Friedreich’s Ataxia 38:48

23h ago38:48

38:48

This podcast and accompanying promotional content has been created in collaboration with and funded by  Biogen. This information is intended for healthcare professionals. The presented content includes mentions of the Skyclarys▼ (omaveloxolone) EU-approved label. Prescribing information for omaveloxolone can be found here. Friedreich's ataxia (FA) …

1
Pneumococcal Infections and the Infant Microbiome:: Translating Microbiome Science into Prevention 11:47

1d ago11:47

11:47

In the final episode, Debby Bogaert discusses how cutting-edge microbiome science is being translated into practice. From novel vaccine approaches to strategies that support the developing microbiome, this conversation highlights how research can drive new preventive solutions to reduce pneumococcal disease and promote healthier lives for children …

1
Pneumococcal Infections and the Infant Microbiome: The Infant Microbiome and Respiratory Health 16:29

1d ago16:29

16:29

In part two, Debby Bogaert unpacks her pioneering research on the infant respiratory microbiome. Discover how early microbial communities in the airways influence immunity, infection risk, and long-term respiratory health — and why nurturing the microbiome could play a critical role in disease prevention. 0:38- Microbiome and Resilience Against Inf…

1
Latest Advances in CAR T-Cell Therapy for Lymphomas and Multiple Myeloma 16:48

5d ago16:48

16:48

In this episode, Dr Brad Kahl and Dr Noopur Raje discuss the recent advances and emerging data for CAR T-cell therapy in lymphomas and multiple myeloma including the latest evidence from long-term clinical trial follow-up and real-world data, plus new data with CAR T-cell therapies in new lymphoma settings and novel CAR T-cell therapies currently u…

1
Pneumococcal Infections and the Infant Microbiome: Pneumococcal Disease in Infancy 17:06

4d ago17:06

17:06

In this first deep dive, Debby Bogaert explores the global burden of pneumococcal disease in young children and compares its impact with RSV and flu. She discusses how pneumococcus colonises the respiratory tract, the role of co-infections, and the importance of vaccination. Listeners will also learn how early life factors and microbiome recovery s…

1
Quickfire: Pneumococcal Infections and the Infant Microbiome 5:53

4d ago5:53

5:53

Get to know Debby Bogaert in this fast-paced quickfire round. She shares the most overlooked aspect of pneumococcal disease, clears up common misconceptions, and reveals the biggest surprise from her research. From advice for new parents to public health leaders, this bite-sized episode is packed with insights Timestamps: 2:14- Overlooked aspect of…

1
Targeting NPM1 in AML with a menin inhibitor; in primates, a CD137 ADC eliminates acute GVHD 15:10

11d ago15:10

15:10

In this week's episode we'll learn about targeting NPM1 in acute myeloid leukemia. Researchers report the first clinical evidence of a menin inhibitor inducing complete remissions in AML with a NPM1 mutation. This validates NPM1 as a new therapeutic target in AML, alongside FLT3, IDH1/2, and KMT2A. Also on the podcast: targeting CD137 to prevent gr…

1
How I Treat Series on Iron Overload in Hematologic Disorders 34:17

8d ago34:17

34:17

Blood Editor, Dr. Thomas Coates interviews Dr. Emanuele Angelucci on his paper, "How I manage iron overload in the hematopoietic cell transplantation setting" which is featured in Blood's "How I Treat Series on Iron Overload in Hematologic Disorders". See the full How I Treat series in volume 145 issue 4 of Blood.…

1
Unpacking Rare Lung Diseases: Interstitial Lung Disease: Treatment Advances & Road Ahead 19:01

8d ago19:01

19:01

In this episode, host Saranya Ravindran is joined by Toby Maher to explore the often-overlooked world of interstitial lung diseases. From clarifying common misconceptions to highlighting AI innovations and personalised treatments, the series dives deep into what clinicians need to know about these serious lung conditions. Whether you're new to inte…

1
Unpacking Rare Lung Diseases: Interstitial Lung Disease: Detection & Diagnosis 15:42

8d ago15:42

15:42

In this episode, host Saranya Ravindran is joined by Toby Maher to explore the often-overlooked world of interstitial lung diseases. From clarifying common misconceptions to highlighting AI innovations and personalised treatments, the series dives deep into what clinicians need to know about these serious lung conditions. Whether you're new to inte…

1
CDK4/6 Inhibitors in HR-Positive/HER2-Negative Breast Cancer: Experts Answer Your Questions 20:20

13d ago20:20

20:20

In this episode, Drs William J. Gradishar, Heather McArthur, and Joanne Mortimer address audience questions from a recent live event on the use of CDK4/6 inhibitors in patients with early and metastatic breast cancer, including: Genomic testing options for assessing risk of recurrence Adjuvant treatment duration and holidays with CDK4/6 inhibitors …

1
Unpacking Rare Lung Diseases: Understanding Interstitial Lung Disease 13:40

12d ago13:40

13:40

In this episode, host Saranya Ravindran is joined by Toby Maher to explore the often-overlooked world of interstitial lung diseases. From clarifying common misconceptions to highlighting AI innovations and personalised treatments, the series dives deep into what clinicians need to know about these serious lung conditions. Whether you're new to inte…

1
Quickfire: Unpacking Rare Lung Diseases: Interstitial Lung Disease 5:12

12d ago5:12

5:12

In this episode, host Saranya Ravindran is joined by Toby Maher to explore the often-overlooked world of interstitial lung diseases. From clarifying common misconceptions to highlighting AI innovations and personalised treatments, the series dives deep into what clinicians need to know about these serious lung conditions. Whether you're new to inte…

1
Onc Now: Episode 24: What Will the Next Decade of HER2-Targeted Therapy Look Like? 35:58

14d ago35:58

35:58

In this episode of Onc Now, host Jonathan Sackier welcomes Komal Jhaveri, Breast Medical Oncologist and clinical investigator at Memorial Sloan Kettering Cancer Center, New York, USA. Known for her trailblazing work in HER2-positive, HER2-low, and hormone receptor-positive breast cancers, Komal Jhaveri discusses how molecular subtyping, antibody-dr…

1
Early prediction of follicular lymphoma patients with poor survival; immune hotspots in aplastic anemia; role of allo-transplant for Hodgkin lymphoma in the checkpoint inhibitor era 19:49

18d ago19:49

19:49

In this week's episode we'll learn about how by combining PET response with circulating tumor DNA, or ctDNA, in newly treated patients with follicular lymphoma, investigators identify those patients likely to progress within 24 months of initial treatment, also known as POD24. After that: Immune hotspots in aplastic anemia. These newly identified h…

1
Preventing Diabetes Complications: Educating Patients and Physicians 15:02

16d ago15:02

15:02

In the final episode of this series on preventative medicine, Vinod Patel discusses how integrated care models, professional training, and patient education improve diabetes outcomes. From chronic fatigue clinics to national screening programs, this episode highlights how innovation in education and collaboration can transform diabetes care across …

1
Preventing Diabetes Complications: A Focus on Diabetic Retinopathy 7:04

16d ago7:04

7:04

What do retinal scans reveal about diabetes complications? In Part 2, Vinod Patel shares insights from his clinical research on diabetic retinopathy, including key risk factors, the impact of hypertension, and the future of screening using advanced imaging tools. A must-listen for clinicians and anyone curious about the eyes-diabetes connection. Ti…

1
Exogenous CD19 stimulation in B-cell acute lymphoblastic leukemia treated with CD19 CAR T-cell therapy, sequential rapid immune-assay in heparin-induced thrombocytopenia diagnosis, and new survival prediction ... 18:42

20d ago18:42

18:42

In this week's episode, we’ll learn more about how exogenous CD19 stimulation affects CAR T-cell persistence in B-cell acute lymphoblastic leukemia treated with CD19 CAR T-cell therapy; new algorithms that incorporate sequential rapid immune-assays, intended to improve diagnosis of heparin-induced thrombocytopenia, and resource-adaptive survival pr…

1
Preventing Diabetes Complications: New Strategies and Technologies 11:05

18d ago11:05

11:05

Vinod Patel joins host Catherine Glass to explore how technology, early intervention, and integrated care are changing diabetes prevention. Learn about the ‘Alphabet Strategy’, machine learning in postpartum prediabetes prediction, and the growing role of glucagon-like peptide-1 (GLP-1) injectables. This episode unpacks how we can identify and redu…

1
Preventing Diabetes Complications: Quickfire 7:21

18d ago7:21

7:21

In this rapid-fire episode, Vinod Patel answers key questions about Type 2 diabetes, from early signs and screening frequency to emerging tech, common misconceptions, and lifestyle advice. Perfect for listeners short on time but eager to boost their diabetes knowledge in just 5 minutes.By EMJ

1
Emerging DLL3-Targeted Therapies for Extrapulmonary Neuroendocrine Carcinomas 29:59

24d ago29:59

29:59

In this episode, Dr. Daniel Morgensztern and Dr. Jonathan Strosberg discuss the emerging role of DLL3-targeted agents in the management of extrapulmonary neuroendocrine carcinomas, including: The clinical implications of using DLL3 as a therapeutic target The impact of emerging DLL3-targeted therapies on evolving treatment paradigms How to incorpor…

1
Hema Now: Episode 23: New Frontiers in Treating Haemoglobinopathies 33:43

21d ago33:43

33:43

In this episode, host Jonathan Sackier is joined by Emanuele Angelucci, Director of Hematology and Cellular Therapies and Director of the Stem Cell Transplant and Cellular Therapies Program at the Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Ospedale Policlinico San Martino Hospital in Genoa, Italy. Timestamps  00:00 – Introduction …

1
How I Treat series on Acute Myeloid Leukemia 42:55

22d ago42:55

42:55

In this episode, Associate Blood editor Dr. Selina Luger leads a discussion with Drs. Courtney DiNardo, Eunice Wang, Andrew Wei and Gail Roboz about the advances in treatment options for Acute Myeloid Leukemia (AML). See the full How I Treat series on Acute Myeloid Leukemia in volume 145 issue 12 of Blood journal.…

1
Available and Emerging Subcutaneous Immunotherapy Treatment Options for Patients With Cancer: A Pharmacy Perspective 24:49

28d ago24:49

24:49

In this episode, listen to Kelly Romo, PharmD, BCOP; and Shauna Kraft, PharmD, BCOP, share their takeaways from a live webinar on available emerging subcutaneous immunotherapy options for patients with cancer including: Basic mechanism of action and role of hyaluronidase in subcutaneous immunotherapy formulation and available dosing/schedules Avail…

1
Tending and Befriending Grief 54:44

26d ago54:44

54:44

In this deeply personal episode, Jonathan Sackier speaks with Zoe Strickland, author of To Grief With Love, about how she navigated the loss of her son and found space for healing through creative expression and connection. They reflect on the evolving nature of grief, the importance of making space for sadness, and the small but powerful ways we c…

1
Daratumumab maintenance in newly-diagnosed, transplant-eligible multiple myeloma; the role of neutrophils in myeloproliferative neoplasms; and novel genetic loci associated with the risk of heavy menstrual ... 15:11

1M ago15:11

15:11

In this week's episode, we’ll learn more about the effects of daratumumab maintenance on minimal residual disease in patients with newly diagnosed, transplant-eligible multiple myeloma; the role of neutrophils in the pathophysiology of myeloproliferative neoplasms; and a genome-wide association study that identified novel genetic loci associated wi…

1
The Pain–Anxiety Connection: Future Directions in Clinical Practice 14:08

30d ago14:08

14:08

In this series, host Catherine Glass speaks with David Cosio about  the complex and often overlooked relationship between anxiety and chronic pain. They explore the neurobiological underpinnings of both conditions, how they influence each other, and what the future of integrated pain management may look like, from AI to psychedelics and beyond. 0:4…

1
The Pain–Anxiety Connection: Mind–Body Interventions 15:55

30d ago15:55

15:55

In this episode, host Catherine Glass speaks with David Cosio about  the complex and often overlooked relationship between anxiety and chronic pain. They explore the neurobiological underpinnings of both conditions, how they influence each other, and what the future of integrated pain management may look like, from AI to psychedelics and beyond.…

1
Onc Now: Episode 23: From Lab to Life in Breast Cancer Care 35:38

1M ago35:38

35:38

In this episode of Onc Now, host Jonathan Sackier is joined by Simon Lord, Associate Professor in Experimental Cancer Therapeutics, University of Oxford, UK, to discuss translating scientific breakthroughs into real-world treatments. With deep expertise in precision medicine and a passion for innovation in oncology, Lord brings a unique perspective…

1
Bonus Episode: Current Trends of Methotrexate Therapy – Do You Know it All? 28:59

1M ago28:59

28:59

This podcast has been funded by medac GmbH. Disclaimer: The views and opinions expressed in this podcast are those of the individual speakers and do not necessarily reflect those of medac GmbH or EMJ. The speakers did not receive honoraria for the recording of this podcast.

2M ago18:51

18:51

In this week's episode, we'll learn about a JAK inhibitor to prevent complications of CD19-directed CAR T-cell therapy. In a phase 2 study, itacitinib was well tolerated and demonstrated promising reductions in the incidence of cytokine release syndrome and neurotoxicity. After that: investigators report direct interactions between ChAdOx1 and plat…